NewsSource: EClinCloud

EClinCloud | Providing More Reliable Digital Solutions for Clinical Research

3 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image

EClinCloud

Digital Solutions for Clinical Research

Article image
Article image
Article image
Article image

EClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") is a technology company focused on clinical R&D. It provides an integrated, interoperable cloud platform for clinical trials and clinical endpoint assessment solutions across therapeutic areas, combining cutting-edge technology with life sciences data to build a leading "patient-centric" SaaS cloud platform for clinical evidence support—helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.

Article image
Article image
Article image
Article image

► Corporate Culture ◄


Article image

Vision

To build a globally leading, "patient-centric," integrated SaaS cloud platform for clinical evidence support through technological innovation and clinical trial endpoint assessment technology

Article image


Mission

Technological innovation to bring effective treatments to patients


Values

Customer success, integrity, innovation


Article image



► Our Team ◄


Article image
Article image


EClinCloud is headquartered at Shenzhen Bay Eco-Technology Park in the heart of the Guangdong-Hong Kong-Macao Greater Bay Area, with offices in Chengdu, Beijing, and Shanghai, as well as a presence in New York, USA, as part of its global expansion.


EClinCloud's core team members each have over 15 years of experience in new drug R&D, supported by more than 110 experienced employees across major cities in China. The team consists primarily of business leaders with a global perspective, KOLs in precision medical evaluation for clinical research, SaaS cloud platform technical experts, and technology innovators. At the same time, we are expanding globally and continuously recruiting industry professionals from well-known domestic and international pharmaceutical companies, CROs, hospital institutions, and leading technology companies.



► Our Products ◄



Article image

01 | Integrated Interoperable Platform

One-stop solutions covering the entire clinical trial lifecycle


EClinCloud's integrated SaaS cloud platform breaks down data silos by bringing previously standalone systems together, enabling data interoperability across systems. This reduces duplicate data entry and cumbersome document management, maximizing the platform's digital value and accelerating the clinical research process.


eCOA

The most specialized and scientific electronic diary and scale collection and assessment system

CTMS

A flexible, lightly customizable clinical trial project management system

eTMF

A trial document management system that improves the success rate of regulatory inspections

EDC

A stable, reliable, efficient, and convenient data capture system

RTSM

A highly secure, accurate, and intelligent randomization system

RM

A resource management system integrating company contracts, personnel, and work hours

eLearning

eLearning training system



02 | Endpoint Assessment Solutions

Driven by science and medicine, providing more reliable clinical endpoint assessment solutions through technological innovation


EClinCloud provides one-stop, therapeutic-area-based clinical endpoint assessment solutions that support the standardization of clinical trial endpoint data and improve data credibility and reliability, thereby improving the success rate of bringing drugs to market. The solutions primarily include: scale copyright management, rater training, eCOA systems, and central reading.



03 | Technology, Intelligence, and Innovation

Exploring innovative pathways for the intelligent transformation of clinical trials

Supported by the integrated application of cutting-edge digital technologies—including big data, artificial intelligence, knowledge graphs, and cloud computing—EClinCloud applies an innovative "Technology + Data + Industry" model to develop intelligent tools that empower the digital transformation of clinical trials, further reducing labor and time costs while improving efficiency.


AI empowers our full product suite. An AI smart assistant powered by natural language models has already been deployed, with further innovations underway...



Article image


Article image


Article image

Contact Us


Strategic partners interested in collaborating with us are welcome to contact us for inquiries.

Contact: Ms. Su

Phone: 18616987169

Email: quanyu.su@eclincloud.com







Article image

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.